RheumNow’s expanded coverage of #ACR26 annual meeting is sponsored by Beeline Medicines, Boehringer Ingelheim, Bristol Myers Squibb, and Tonix. All coverage content is independently selected by RheumNow and its faculty.

@Aclockworkolive @drdavidliew @NEJM @RheumNow Both rap-cel and zola-cel targets to keep the infusion material enriched in CCR7+CD27+ naive state, for which the ex vivo part of the expansion has to be stopped before the cells start differentiating. Longer the ex vivo culture, higher the percentage of differentiation.

Points to consider to D2M AxSpA Mimics + Interfering Factors: Nociplastic Pain Degenerative Joint/Spine/SI/Hip disease Fracture Infection Malignancy Mental/psychosocial factors Poor sleep Other (crystalline arthritis, metabolic bone disease) Abst2944 #ACR26 @RheumNow

RheumNow’s expanded coverage of #ACR26 is sponsored by Eli Lilly and Company. All coverage content is independently selected by RheumNow and its faculty.

RheumNow’s expanded coverage of the #ACR26 Annual Meeting is sponsored by UCB. All coverage content is independently selected by RheumNow and its faculty.

In the ALLIANCE randomised trial, 82 physicians worked through three rheumatology vignettes with or without a certified large language model decision support system. The decision support system alone reached 33.3% top diagnosis accuracy against 27.0% for unassisted